ylliX - Online Advertising Network
Company Ticker News

Medtronic’s Evolut Pro TAVR Approved In China, Acquires Cardiac Arrhythmia Treatment Developer Affera

Medtronic's Evolut Pro TAVR Approved In China, Acquires Cardiac Arrhythmia Treatment Developer Affera

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Medtronic Plc’s (NYSE: MDT) CoreValve Evolut Pro TAVR system has received National Medical Products Administration approval in China. The approval marks the first Medtronic TAVR system approved in China for patients with symptomatic severe aortic stenosis at high or extreme risk for open-heart surgery.

...read full article on Benzinga

ylliX - Online Advertising Network